Stocks
Global Blood Therapeutics (GBT) EV/EBITDA US GAAP (year values) |
|||||||||
| 2017 | 2018 | 2019 | 2020 | 2021 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -11.7 | -9.57 | -16.0 | -9.91 | -6.52 | -15.8 | ||
| Changes by years, y/y, % | +188% | -18% | +67% | -38% | -34% | +9.9% | |||
Global Blood Therapeutics. EV/EBITDA
Global Blood Therapeutics. EV/EBITDA, changes, %
Global Blood Therapeutics (GBT) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2021Q2 | 2021Q3 | 2021Q4 | 2022Q1 | 2022Q2 | LTM ? | |||
| EV/EBITDA | ? | -8.07 | -5.70 | -6.68 | -8.38 | -7.76 | -15.8 | |
| Changes by years, y/y, % | -31% | -46% | -32% | -16% | -4% | |||
| Changes by quarters, q/q, % | -19% | -29% | +17% | +26% | -7% | |||
